Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-019620

Director sold 2,000 shares at $44.56 ($89,120)

  • Director acquired 2,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

HERSHBERG ROBERT · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-08 Exercise or conversion : show line 1 in the form +2,000 $0.45 $900 2,000 D
2021-03-08 Sale : show line 2 in the form −2,000 $44.56 $89,120 0 D
Open-market sales · 2,000 sh · avg $44.56 · $89,120

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-08 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −2,000 53,000 D
Loading xslF345X03/doc4.xml…